Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights
FDA accepted for filing the Biologics License Application for cosibelimab in patients with metastatic or…
Month: March 2023
HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer
— NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe,…
Additional Detailed Analyses From Phase 2 Study 201 of Lecanemab Published as Three Papers in Peer-Reviewed Journals
TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo,…
Eisai Presented New Analyses of ARIA and QOL on Lecanemab in Clarity AD at the AD/PD™ 2023 Annual Meeting
TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo,…
Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update
Announces strategic reprioritization to focus on clinical development of MT-6402, MT-8421, and MT-0169, and preclinical…
FansUnite Reports Full Year 2022 Financial Results
Total revenue of $27.30 million for the full year of Fiscal 2022, an increase of…
Microvast Announces Location of First Polyaramid Separator Plant in Kentucky
HOUSTON–(BUSINESS WIRE)–Microvast Holdings, Inc. (NASDAQ: MVST), (“Microvast” or the “Company”), a technology innovator that designs,…
kipi.bi Announces Launch of WatchKeeper™ Monitoring Accelerator for Snowflake
Enabling self-service monitoring and optimization for Snowflake customers FRISCO, Texas–(BUSINESS WIRE)–#elitepartner—kipi.bi, a modern data engineering,…
Humantic AI Partners with Sandler to Redefine Sales Training in the Age of AI
PALO ALTO, Calif.–(BUSINESS WIRE)–#buyerintelligence–Humantic AI, the world’s first buyer intelligence platform, leverages cutting-edge AI to…
amazee.io Now Available in AWS Marketplace
New offering allows AWS customers to deploy and run modern applications on Kubernetes SAN FRANCISCO–(BUSINESS…
PACCAR and Platform Science Announce Strategic Equity Investment
BELLEVUE, Wash.–(BUSINESS WIRE)–PACCAR announced today that it has made a minority equity investment in its…
Berkeley SkyDeck Hosts 15th Demo Day, Featuring 18 Startups
The highly competitive Batch 15, which saw a 120% increase in applicants from the previous…
Presto Promotes Dan Mosher to President and Xavier Casanova to Chief Operating Officer
SAN CARLOS, Calif.–(BUSINESS WIRE)–$PRST—Presto Automation Inc. (Nasdaq: PRST), one of the largest drive-thru automation technology…
Enterprise Connect 2023 Brought the $270.3 Billion Enterprise Communications and Customer Experience Community Together to Explore the Trends and Technologies Driving the Industry
Enterprise Connect 2024 Takes Place March 25-28 in Orlando, FL SAN FRANCISCO–(BUSINESS WIRE)–Enterprise Connect, the…
Lowell Farms Inc. Announces Audited Fourth Quarter and Fiscal Year 2022 Financial and Operational Results
SALINAS, Calif., March 30, 2023 (GLOBE NEWSWIRE) — Lowell Farms Inc. (the “Company”) (CSE: LOWL;…
GT Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update
Proforma cash of approximately $23.0 million includes $16.5 million in cash as of December 31,…
Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion
Company announcement – No. 11 / 2023 Zealand Pharma announces completion of a directed issue…
Galapagos and NovAliX enter into an integrated drug discovery collaboration
Galapagos to transfer drug discovery and research activities in Romainville, France to NovAliX, a drug-discovery…
Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones
– Sutro plans to initiate a Phase 2/3 registration-directed study of luvelta for patients with…
Structure Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
Completed dosing of Phase 1b study of oral GLP-1 agonist GSBR-1290Topline data from Phase 1b…